NEW YORK, March 3, 2020 /PRNewswire/ -- RIND Snacks®, providers of "skin-on superfruit" snacks, has added both a new product and three national grocery chains to keep up with consumers' increasing hunger for the brand. "Coco-Melon" debuts as the company's fifth addition to its product line, featuring a three-ingredient blend of organic coconut, watermelon, and c

DUBLIN and TORONTO, March 3, 2020 /PRNewswire/ -- Avectas, a cell engineering technology business, and CCRM, a leader in developing and commercializing cell and gene therapies, today announced they have entered into a collaboration to accelerate the translation of Avectas' non-viral cell engineering platform (Solup

LOS ANGELES, March 3, 2020 /PRNewswire/ -- MAX BioPharma, Inc. (www.maxbiopharma.com) recently published an article describing its anti-tumorigenic oxysterol lead compound, Ox

DENVER, March 3, 2020 /PRNewswire/ -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announces the introduction of the 5G-enable

IRVINE, Calif., March 3, 2020 /PRNewswire/ -- With decades of experience providing unparalleled in-home care to clients and their families nationwide, Comfort Keepers® has been recognized by Newsweek as "America's Best Customer Service" in the category of Home Care Services for Seniors and Disabled. With one of the largest network of caregivers acros

HOUSTON, March 3, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announces as of February 2020, a patient from the Phase 1 clinical tr

HOUSTON, March 3, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the results from its pivotal cellulite trial hav

LONDON, March 3, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the US launch of the new PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) which has a pump duration of up to 14 days.1 The new pump builds on the features and advantages of previous PICO sNPWT variants, and c

NORTH CHICAGO, Ill. and DUBLIN, March 3, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the European Commission has approved the divestiture of brazikumab, an investigational IL-23 inhibitor in dev

SEATTLE and RIYADH, Saudi Arabia, March 3, 2020 /PRNewswire/ -- TransformativeMed, which transforms electronic health records (EHRs) with directly embe